“There remains an opportunity to further the understanding of interactions of MS and menopause to help guide women with MS and provide additional insights about hormonal influences in MS at…

Lots of time at the microscope and passion work are part of a typical workday for this pathologist.

Today’s early morning highlights from the major news organizations.

SAN FRANCISCO, Feb. 22, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), announced today that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer,

SAN FRANCISCO, Feb. 22, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), announced today that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview and upda…

Read more about Reuters Health News Summary on Devdiscourse

Read more about Health News Roundup: AstraZeneca boosts oncology credentials with breast cancer trial success; Top Colombia court decriminalizes abortion until 24 weeks of gestation and more on Devdiscourse

Around one in seven women going through the menopause in England are believed to be on HRT, which can help to relieve symptoms such as hot flushes, night sweats and depression.

Courteney Cox used to look a bit different several years ago. In a new interview, she talked about how she felt about her past cosmetic treatments.

Bold Types is a weekly roundup of the movers and shakers in Boston’s business business scene.